s/no | Authors/Country/Regions | Study design | Population | Period | Outcome |
---|---|---|---|---|---|
1 | Chen J et al. Africa | Systematic Review/Meta-analysis | Frontline/General/ HCWs/4,847 | Dec.2019–April 2020 | Anxiety 51%, depression 45%, and insomnia 28% |
2 | Pappa S et al. China | Systematic Review/Meta-analysis | HCWs, 33,062 | 17 April 2020 | Anxiety 23.2%, depression 22.8%, and Insomnia 38.9% |
3 | Li Y, et al. China | Systematic Review/Meta analysis | HCWs 33,062 | 17 April 2020 | Anxiety 22.1%, depression 21.7%, and PTSD 21.5% |
4 | Basreeqa SB et al. China | Systematic Review/Meta analysis | General Population Frontline/General HCWs. 62,382 | First six months of 2020 | Anxiety 48.1%, depression 26.9%, and Stress 48.1% |
5 | Preti E et al., Asia, Middle East, Europe, USA | Rapid Review | HCWs | March 2020 | Anxiety 45%, depression 27.5–50.7%, Stress 18.1–80.1%, Insomnia 34–36%, and PTSD 11–73.4% |
6 | Lai J. China | Cross-sectional | HCWs | First six months of 2020 | Anxiety 44.6%, depression 50.4%, distress 71.5%, and insomnia 34% |
7 | Tan BYQ. Singapore | Cross-sectional | General population /HCWs | First six months of 2020 | Anxiety 14.5%, depression8.9%, Stress 6.6%, and PTSD 7.7% |
8 | Consolo U et al. Italy | Cross-sectional | HCWs | First six months of 2020 | Anxiety 46.4%, depression 70.2%, and stress 42.4% |
9 | Gilleen J et al. UK | Cross-sectional | HCWS | First six months of 2020 | Anxiety 33%, Depression 28%, and PTSD 15% |
10 | Shacther A, et al. NY, USA | Cross-sectional | HCWs | First six months of 2020 | Anxiety 33%, depression 48%, and stress 57% |
11 | Urooj U, et al. Pakistan | Cross-sectional | HCWs | First six months of 2020 | Anxiety 86%, depression 58%, and stress 28.8% |
12 | Wilson W, et al. India | Cross-sectional | HCWs | First six months of 2020 | Anxiety 17.7%, depression 11.6%, and stress 3.7% |
13 | Elhadi M, et al. Libya | Cross-sectional | HCWs | Early 2022 | Anxiety 46.7%, and depression 56.3% |